Drug Trial Radar · NCT04519658
A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)
Last checked: Nov 20, 2026Latest source record: Jul 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
275
Actual
Start
Oct 12, 2020
Primary completion
Jun 14, 2022
Study completion Jun 14, 2022
Sponsor
- Lead sponsor
- CinCor Pharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 20, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, dose-ranging Phase 2 study to evaluate the efficacy and safety of CIN-107 as compared to placebo after 12 weeks of treatment in patients with treatment-resistant hypertension (rHTN).
Conditions
- Resistant Hypertension
Interventions
CIN-107Drug
CIN-107 tablets by mouth once daily
PlaceboDrug
placebo tablets by mouth once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Mean Seated Systolic BP (SBP)Time frame: 12 weeks
Locations
80 sites in 1 country. Site status is shown where the registry gives one.
CinCor Site 16
Birmingham, Alabama
CinCor Site 38
Birmingham, Alabama
CinCor Site 61
Saraland, Alabama
CinCor Site 90
Tucson, Arizona
CinCor Site 82
Anaheim, California
CinCor Site 91
Granada Hills, California
CinCor Site 25
Lincoln, California
CinCor Site 73
Los Angeles, California
CinCor Site 36
Los Angeles, California
CinCor Site 34
Lynwood, California
CinCor Site 14
San Dimas, California
CinCor Site 28
Santa Ana, California
CinCor Site 19
Spring Valley, California
CinCor Site 32
Tustin, California
CinCor Site 44
West Hills, California
CinCor Site 66
Whittier, California
CinCor Site 56
Stamford, Connecticut
CinCor Site 30
Clearwater, Florida
CinCor Site 13
Fort Myers, Florida
CinCor Site 74
Hialeah, Florida
CinCor Site 22
Homestead, Florida
CinCor Site 20
Jacksonville, Florida
CinCor Site 1
Jupiter, Florida
CinCor Site 84
Lake Worth, Florida
CinCor Site 70
Miami, Florida
CinCor Site 89
Miami, Florida
CinCor Site 94
Miami, Florida
CinCor Site 5
Port Orange, Florida
CinCor Site 9
St. Petersburg, Florida
CinCor Site 23
Tampa, Florida
CinCor Site 88
Winter Haven, Florida
CinCor Site 71
Suwanee, Georgia
CinCor Site 11
Meridian, Idaho
CinCor Site 15
Addison, Illinois
CinCor Site 81
Arlington Heights, Illinois
CinCor Site 49
Chicago, Illinois
CinCor Site 35
Morton, Illinois
CinCor Site 58
Evansville, Indiana
CinCor Site 54
West Des Moines, Iowa
CinCor Site 29
Lexington, Kentucky
Showing 40 of 80 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.